INSUGEN 50/50 40 IU 10ML

About

Insugen 50/50 is a biphasic insulin formulation, a pre-mixed insulin designed to provide both rapid-acting and intermediate-acting effects in a single injection. The rapid-acting component (Insulin Regular) helps control post-meal glucose spikes, while the intermediate-acting component (Insulin NPH) provides basal insulin coverage throughout the day. This combination simplifies the insulin regimen for many patients, reducing the number of daily injections. The specific ratio (50% Regular, 50% NPH) determines the balance between immediate and sustained glucose control, allowing for individualized treatment based on a patient's glycemic profile and lifestyle.

Uses

• Management of Type 1 Diabetes Mellitus.
• Management of Type 2 Diabetes Mellitus.
• Simplification of complex insulin regimens.
• Control of both basal and postprandial glucose.

Directions For Use

Administer subcutaneously, usually 15-30 minutes before a meal, as directed by your physician. Gently roll the vial before use.

Benefits

• Provides both rapid and sustained glucose control.
• Reduces the number of daily injections.
• Convenient for patients requiring mixed insulin.
• Helps manage both mealtime and basal glucose.
• Improves adherence to insulin therapy.
• Offers a balanced approach to glycemic management.

Side Effects

• Hypoglycemia (low blood sugar)
• Injection site reactions (redness, swelling, itching)
• Lipodystrophy
• Weight gain
• Peripheral edema
• Allergic reactions (rare)
• Rash
• Pruritus
• Urticaria
• Bronchospasm
• Hypotension
• Anaphylaxis (very rare)

Safety Measures

• Alcohol - Alcohol can lower blood sugar and increase the risk of hypoglycemia when used with insulin. Consume in moderation, if at all, and monitor blood glucose closely.
• Pregnancy - Insulin is generally considered safe and is the preferred treatment for diabetes in pregnancy. Close monitoring and dose adjustments are essential.
• Breastfeeding - Insulin is safe to use during breastfeeding as it does not pass into breast milk in significant amounts.
• Liver - Patients with liver impairment may require insulin dose adjustments due to altered glucose metabolism and insulin clearance.
• Kidney - Renal impairment can prolong insulin action and increase the risk of hypoglycemia; dose adjustments are often necessary.
• Lung - No specific contraindications or precautions related to lung conditions for insulin use.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.